FR1203M - New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism. - Google Patents

New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.

Info

Publication number
FR1203M
FR1203M FR848182A FR848182A FR1203M FR 1203 M FR1203 M FR 1203M FR 848182 A FR848182 A FR 848182A FR 848182 A FR848182 A FR 848182A FR 1203 M FR1203 M FR 1203M
Authority
FR
France
Prior art keywords
hyperestrogenia
hypoandrogenism
treatment
new drug
disorders due
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR848182A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR848182A priority Critical patent/FR1203M/en
Priority to SE1034761A priority patent/SE300972B/xx
Priority to GB3769861A priority patent/GB930885A/en
Priority to BR13367861A priority patent/BR6133678D0/en
Priority to ES271517A priority patent/ES271517A1/en
Priority to DK425261A priority patent/DK104567C/en
Priority to CH1244961A priority patent/CH395978A/en
Priority to BE609700A priority patent/BE609700A/en
Application granted granted Critical
Publication of FR1203M publication Critical patent/FR1203M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
FR848182A 1960-10-27 1960-12-28 New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism. Active FR1203M (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR848182A FR1203M (en) 1960-10-27 1960-12-28 New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.
SE1034761A SE300972B (en) 1960-10-27 1961-10-18
GB3769861A GB930885A (en) 1960-10-27 1961-10-20 Processes for the production of steroid esters and the new steroid esters thus produced
BR13367861A BR6133678D0 (en) 1960-10-27 1961-10-25 PROCESS OF PREPARATION OF NEW ESTERS OF STEROID COMPOUNDS
ES271517A ES271517A1 (en) 1960-10-27 1961-10-26 A procedure for the preparation of new esteroid esters (Machine-translation by Google Translate, not legally binding)
DK425261A DK104567C (en) 1960-10-27 1961-10-26 Process for the preparation of 17-monocyclohexylcarbonates of 17-hydroxysteroids of androstanels of the oyster row, 3-monocyclohexylcarbonates of 3-hydroxysteroids of the oyster row or 3,17-dicyclohexylcarbonates of 3,17-dihydroxysteroids of the oyster row.
CH1244961A CH395978A (en) 1960-10-27 1961-10-27 Process for the preparation of new esters of steroid compounds
BE609700A BE609700A (en) 1960-10-27 1961-10-27 Novel esters of steroid compounds and method of preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR842375A FR1365267A (en) 1960-10-27 1960-10-27 Novel cyclohexylcarbonates of steroid compounds and method of preparation
FR848182A FR1203M (en) 1960-10-27 1960-12-28 New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.

Publications (1)

Publication Number Publication Date
FR1203M true FR1203M (en) 1962-03-26

Family

ID=8741608

Family Applications (3)

Application Number Title Priority Date Filing Date
FR842375A Expired FR1365267A (en) 1960-10-27 1960-10-27 Novel cyclohexylcarbonates of steroid compounds and method of preparation
FR848182A Active FR1203M (en) 1960-10-27 1960-12-28 New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.
FR850722A Active FR1172M (en) 1960-10-27 1961-01-25 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR842375A Expired FR1365267A (en) 1960-10-27 1960-10-27 Novel cyclohexylcarbonates of steroid compounds and method of preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR850722A Active FR1172M (en) 1960-10-27 1961-01-25 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Country Status (1)

Country Link
FR (3) FR1365267A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531089B1 (en) * 1982-07-27 1986-03-21 Pharmascience Lab NOVEL OESTRANIC DERIVATIVES FOR TOPICAL PHARMACOLOGICAL APPLICATIONS AND THEIR PREPARATION METHOD

Also Published As

Publication number Publication date
FR1172M (en) 1962-03-12
FR1365267A (en) 1964-07-03

Similar Documents

Publication Publication Date Title
FR2713M (en) New drug in particular for the treatment of manifestations of hypoandrogenism, disorders of protein anabolism as well as for the treatment of hyperfolliculinia.
FR1994M (en) New drug in particular for the treatment of manifestations due to hyperlipemia or hypercholesterolemia.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1203M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR342M (en) New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR1487M (en) New drug in particular for the treatment of disorders due to hyperlipemia.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1513M (en) New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability.
FR1372M (en) New drug, in particular for the treatment of manifestations of hyperemotion, anxiety and disorders due to hyperexcitability.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR2913M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3269M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2574M (en) New drug, in particular for the treatment of pain and inflammatory symptoms.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR3190M (en) New drug, in particular for the treatment of uric acid elimination disorders.
FR1690M (en) New drug in particular for the treatment of respiratory disorders, bronchitis, pneumonia and heart collapse and failure.
FR3641M (en) New drug in particular for the treatment of states of adynamia.
FR3009M (en) New drug in particular for the treatment of protein anabolism and disorders due to hyperfolliculinia.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.